Biopower Operatn Financials
This page shows Biopower Operatn (BOPO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
BioPower’s reported business looks dominated by balance-sheet strain, with tiny operating assets carrying nearly $6.0M of obligations.
From FY2020 to FY2022, total liabilities climbed from$4.36M to$5.95M even as cash liquidity shrank from$96K in FY2021 to$825 and equity stayed deeply negative. That combination says reported financing and operating activity were not rebuilding the balance sheet; they were mainly offsetting ongoing deficits while immediate liquidity got thinner.
FY2021 shows the operating mismatch clearly:
By FY2022, liquidity-bearing assets were extremely thin: of just
Financial Health Signals
We are recalculating Biopower Operatn's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Key Financial Metrics
Earnings & Revenue
Cash & Balance Sheet
Biopower Operatn held $825 in cash against $0 in long-term debt as of fiscal year 2022.
Biopower Operatn had 46M shares outstanding in fiscal year 2022. This represents an increase of 1.4% from the prior year.
Margins & Returns
Capital Allocation
BOPO Income Statement
| Metric | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $125K-49.3% | $247K+23.4% | $200K | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $51K | N/A | $403K+89.9% | $212K+40.3% | $151K | N/A | $201K |
| Operating Income | N/A | N/A | N/A | -$278K-912.8% | $34K-29.5% | $49K | N/A | -$201K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | -$244K-1755.0% | -$13K-1213.4% | $1K | N/A | -$244K |
| EPS (Diluted) | $-0.10 | N/A | N/A | N/A | $0.00 | N/A | N/A | N/A |
BOPO Balance Sheet
| Metric | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13K-1.0% | $13K-4.9% | $14K-76.8% | $61K-90.1% | $613K+168.4% | $228K+138.1% | $96K-47.1% | $181K |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | N/A | $135-83.6% | $825-94.5% | $15K-97.1% | $522K+6059.1% | $8K-91.2% | $96K-47.1% | $181K |
| Inventory | $13K0.0% | $13K0.0% | $13K0.0% | $13K0.0% | $13K | N/A | N/A | N/A |
| Accounts Receivable | $3310.0% | $3310.0% | $3310.0% | $3310.0% | $331-99.8% | $200K | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.9M+5.1% | $6.6M+10.1% | $6.0M+9.5% | $5.4M-6.0% | $5.8M+2.6% | $5.6M+2.4% | $5.5M+0.7% | $5.5M |
| Current Liabilities | $6.9M+5.1% | $6.6M+10.1% | $6.0M+9.5% | $5.4M-6.0% | $5.8M+2.6% | $5.6M+2.4% | $5.5M+0.7% | $5.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$6.9M-5.1% | -$6.5M-10.1% | -$5.9M-10.4% | -$5.4M-4.0% | -$5.2M+4.4% | -$5.4M0.0% | -$5.4M-2.3% | -$5.3M |
| Retained Earnings | -$15.7M-43.3% | -$11.0M-6.1% | -$10.3M-5.5% | -$9.8M-2.5% | -$9.6M-0.1% | -$9.6M0.0% | -$9.6M-1.3% | -$9.4M |
BOPO Cash Flow Statement
| Metric | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$380+44.9% | -$690+99.0% | -$69K-134.8% | $199K-24.5% | $264K+401.5% | -$87K-2.6% | -$85K | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | $55K | N/A | N/A | N/A | $0 | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BOPO Financial Ratios
| Metric | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | -222.8%-236.6pp | 13.9%-10.4pp | 24.3% | N/A | N/A |
| Net Margin | N/A | N/A | N/A | -195.0%-189.6pp | -5.3%-5.9pp | 0.6% | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | -402.6%-400.4pp | -2.1%-2.7pp | 0.5% | N/A | -134.7% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$5.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What are Biopower Operatn's total assets?
Biopower Operatn (BOPO) had $14K in total assets as of fiscal year 2022, including both current and long-term assets.
Why is Biopower Operatn's debt-to-equity ratio negative or not reported?
Biopower Operatn (BOPO) has negative shareholder equity of -$5.9M as of fiscal year 2022, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.